These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31258617)

  • 1. Use of botulinum toxin for movement disorders.
    Camargo CHF; Teive HAG
    Drugs Context; 2019; 8():212586. PubMed ID: 31258617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin in Movement Disorders: An Update.
    Anandan C; Jankovic J
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33430071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin for the Management of Parkinson's Disease: A Systematic Review.
    Slouha E; Ibrahim F; Esposito S; Mursuli O; Rezazadah A; Clunes LA; Kollias TF
    Cureus; 2024 Jan; 16(1):e53309. PubMed ID: 38435899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin for the Treatment of Tremor and Tics.
    Lotia M; Jankovic J
    Semin Neurol; 2016 Feb; 36(1):54-63. PubMed ID: 26866497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperkinetic movement disorders.
    Jankovic J
    Lancet Neurol; 2009 Sep; 8(9):844-56. PubMed ID: 19679276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of botulinum toxin in neurological indications.
    Ward AB; Molenaers G; Colosimo C; Berardelli A
    Eur J Neurol; 2006 Dec; 13 Suppl 4():20-6. PubMed ID: 17112346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Therapy for Parkinson's Disease.
    Wagle Shukla A; Malaty IA
    Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.
    Jellinger KA
    J Neural Transm (Vienna); 2019 Aug; 126(8):933-995. PubMed ID: 31214855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in movement disorders.
    Tater P; Pandey S
    Neurol India; 2018; 66(Supplement):S79-S89. PubMed ID: 29503330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin.
    Maria G; Cadeddu F; Brisinda D; Brandara F; Brisinda G
    Curr Med Chem; 2005; 12(3):247-65. PubMed ID: 15723617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement disorders after head injury: diagnosis and management.
    O'Suilleabhain P; Dewey RB
    J Head Trauma Rehabil; 2004; 19(4):305-13. PubMed ID: 15263858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Treatment of Movement Disorders.
    Safarpour Y; Jabbari B
    Curr Treat Options Neurol; 2018 Feb; 20(2):4. PubMed ID: 29478149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the use of botulinum toxin therapy in Parkinson's disease.
    Mills R; Bahroo L; Pagan F
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When movement disorders hurt: Addressing pain in hyperkinetic disorders.
    Relja M; Miletić V
    Parkinsonism Relat Disord; 2017 Nov; 44():110-113. PubMed ID: 29111426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.